Business Description
Arch Biopartners Inc
NAICS : 325410
SIC : 3741
ISIN : CA03938C1041
Description
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | -7.87 | |||||
Debt-to-Equity | -0.7 | |||||
Debt-to-EBITDA | -1.1 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -3.6 | |||||
3-Year Book Growth Rate | 6.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.31 | |||||
9-Day RSI | 70 | |||||
14-Day RSI | 70.13 | |||||
3-1 Month Momentum % | -18.38 | |||||
6-1 Month Momentum % | -64.88 | |||||
12-1 Month Momentum % | -77.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Cash Ratio | 0.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | -2.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -919.8 | |||||
ROIC % | -95.62 | |||||
3-Year ROIIC % | -41.01 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -27.26 | |||||
EV-to-EBITDA | -27.26 | |||||
EV-to-Forward-Revenue | 51 | |||||
EV-to-FCF | -57.91 | |||||
Earnings Yield (Greenblatt) % | -3.67 | |||||
FCF Yield % | -1.78 |
GF Valueâ„¢
Arch Biopartners Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arch Biopartners Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guru Commentaries on OTCPK:ACHFF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arch Biopartners Inc
No articles.